
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
RR\ID is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints. We are an evolution of Rapid Reviews: COVID-19 (RR\C19), which won the 2022 PROSE Award for Innovation in Journal Publishing for introducing a new peer review model facilitating rapid publishing of COVID-19-related research preprints. RR\ID expands beyond COVID-19 to advance our understanding of infectious diseases, leaning on a similar curate, review, publish model. RR\ID aims to prevent the dissemination of false/misleading scientific information and accelerate the validation and diffusion of robust findings. RR\ID aims to increase the application of science for the common good,...
Open science,peer review,infectious diseases,public health,medical sciences,social sciences and humanities,biological and chemical sciences,and physical sciences and engineering
Rapid reviews\infectious diseases operates in the Book and periodical publishing industry.
Rapid reviews\infectious diseases's revenue is 11m - 100m
Rapid reviews\infectious diseases has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.